Search



Search only items with full text availability
Current filters:

Clear current filters  or Add more filters

View Option



Results 11-20 of 24 (Search time: 0.003 seconds).

  Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients (Journal article)

  Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study (Journal article)

  Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia (Journal article)

  Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis (Journal article)

  A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia (Journal article)

  The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol (Journal article)

  The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes (Journal article)

  Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia (Journal article)

  The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome (Journal article)

  Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatment (Journal article)